Quarterly report pursuant to Section 13 or 15(d)

EQUITY

v3.22.2
EQUITY
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Equity EQUITY
Accumulated Other Comprehensive Income (Loss)
The following table presents changes in the components of AOCI, net of taxes, for the six months ended June 30, 2022:
Cash Flow Hedge  Foreign Currency Items Total
(in thousands)
Balance at December 31, 2021 $ (8,558) $ (139,406) $ (147,964)
Other comprehensive income before reclassifications
31,656  (16,412) 15,244 
Amount reclassified from AOCI 3,149  —  3,149 
Net other comprehensive income 34,805  (16,412) 18,393 
Balance at June 30, 2022 $ 26,247  $ (155,818) $ (129,571)
Earnings Per Share
Basic net income (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. The calculation of diluted net income (loss) per common share includes the effects of the assumed exercise of any outstanding stock options, the assumed vesting of shares of restricted and deferred stock awards and the assumed conversion of our convertible senior notes, where dilutive.
The following table sets forth the computation of weighted average common shares outstanding:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022 2021 2022 2021
Weighted average common shares—basic 224,674,447  215,702,508  223,290,226  215,120,467 
Effect of dilutive securities:
    Stock options and restricted stock 7,096,282  —  8,077,448  — 
    Convertible senior notes 11,864,035  —  —  — 
Weighted average common shares—diluted 243,634,764  215,702,508  231,367,674  215,120,467 

The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022 2021 2022 2021
Options to purchase shares of common stock 3,750  7,797,075  3,750  7,797,075 
Restricted stock and deferred stock—unvested 259,200  3,007,032  211,922  3,007,032 
Conversion shares related to the convertible senior notes —  11,864,035  11,864,035  11,864,035 
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding 262,950  22,668,142  12,079,707  22,668,142